Newly Listed Fractal Crosses Rs 100 Cr PAT in Q3

• Revenue Grows 21%, Adjusted EBITDA Grows Even Faster at 24% YoY
• Improves Gross Margin to 47.2%, considered Best in Class

MUMBAI, India, March 5, 2026 /PRNewswire/ — Fractal Analytics Ltd (BSE: 544700) (NSE: FRACTAL) announced its consolidated financial results for Q3 FY 2026, ending December 31, 2025.

In Q3 FY26, the Company reported consolidated revenue of Rs 854.4 Cr, a growth of 21% year on year (YoY). Growth was led by strong demand in the Healthcare and Life Sciences segment (20% of revenue) which grew 78% YoY and the Banking and Financial Services segment (12% of revenue) which grew 26% YoY.

Fractal further expanded its relationships with existing clients resulting in a Net Revenue Retention* of 114% in Q3 FY26. Fractal’s Net Promoter Score (NPS) during the period stood at 77.

The number of clients who generate revenues upwards of $20 million increased by 2 YoY to 6 clients. The number of clients who generate more than $1 million went by 8 YoY to 58 clients.

The company reported a Gross Margin of 47.2%, an expansion of 0.2% YoY. Adjusted EBITDA outperformed revenue growth, clocking 24% growth YoY to Rs 152.1 Cr. Adjusted EBITDA margin was at 17.8%, an expansion of 0.4% YoY. Profit after Tax was Rs 100.1 Cr.

Fractal Products beating Global Benchmarks

The company’s consumer-targeted AI-based health assistant, Vaidya.ai 2.0, became the first AI model to achieve a 50+ score on OpenAI’s HealthBench (Hard), one of the toughest healthcare benchmarks that measure advanced clinical reasoning across complex diagnostic scenarios, outperforming ChatGPT-5, GPT-5.2 and Gemini Pro 3.

PiEvolve, an evolutionary agentic engine designed for autonomous machine learning and scientific discovery, was ranked among the top-performing agents on OpenAI’s MLE-Bench, outperforming agents from leading AI research labs, including Google, Microsoft and Meta.

Commenting on the performance, Srikanth Velamakanni, Group CEO and Executive Vice-Chairman said: “ We delivered a great quarter, improving across nearly every metric. Our best-in-class organic growth, gross margins, and high client retention reflect the strength of our enterprise AI capabilities and the trust our clients place in us.

We have built a disciplined, high-performance organization focused on solving complex enterprise problems with AI. As adoption scales across industries, Fractal is well positioned to lead this transformation while creating sustained long-term value for our clients and shareholders.”

For more information, please visit the Investor Relations section of our website at https://fractal.ai/investor-relations

About Fractal

Fractal is a publicly listed global enterprise AI company with a vision to power every human decision in the enterprise. With a workforce of over 5,000 professionals across North America, EMEA, and Asia-Pacific, Fractal partners with Fortune 500® companies to embed AI into critical business decisions across growth, supply chains, pricing, and customer experience.

Committed to sustained innovation, Fractal invests more than 5% of its annual revenue in AI research and development, supporting foundational AI research, product development, and IP creation that address both immediate client needs and long-term technological advancement.

The company reported consolidated revenue of Rs 27.6 billion for the fiscal year ended March 31, 2025, representing a 30% CAGR over the past decade. Following a successful IPO in February 2026, Fractal is listed on the BSE and NSE in India.

For more information, go to www.fractal.ai.

*Net Revenue Retention in our Fractal.ai segment measures how effectively we retain and expand revenue from our existing clients over a defined period and is calculated by comparing the current period’s revenue from the clients who existed at the start of the period, with their revenue in the previous period – including the effects of upsells, cross sells and contractions

View original content:https://www.prnewswire.com/in/news-releases/newly-listed-fractal-crosses-rs-100-cr-pat-in-q3-302705770.html